Drugs / Vagitocin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01975129 | Sep 2013 → Feb 2014 | postmenopausal atrophic vaginitis | PepTonic Medical AB | Completed | No outcome recorded |
Press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2013-12-15 | PepTonic Medical AB | First evaluation of VAGITOCIN® packaging completed peptonicmedical.se ↗ |
| 2013-12-14 | PepTonic Medical AB | Last patient completed VAGITOCIN® PK study peptonicmedical.se ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vagitocin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01975129 ↗ |
| Route | Other | “intravaginal administration of Vagitocin 400IU” NCT01975129 ↗ |